Malignant tumours and psoriasis: A follow-up study

British Journal of Dermatology

Volumn 140, Issue 2, 1999, Pages 237-242

  Frentz, G ^b   Olsen, Jorgen H ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b NONE

Author keywords

Lifetime risk; Malignant tumours; Non melanoma skin cancer; Psoriasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; FEMALE; FOLLOW UP; HUMAN; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PHARYNX CANCER; PRIORITY JOURNAL; PSORIASIS; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0033062518     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02655.x     Document Type: Article

References (16)

1. Studniberg HM, Weller P. PUVA, UVB, psoriasis and nonmelanoma skin cancer. J Am Acad Dermatol 1993; 29: 1013-22.
2. Stern RS, Lange R. Cardiovascular disease, cancer and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988; 91: 197-201.
3. Sommers SC, McManus RG. Multiple arsenical cancers of skin and internal organs. Cancer 1953; 6: 347-59.
4. Olsen JH, Møller H, Frentz G. Malignant tumors in patients with psoriasis. J Am Acad Dermatol 1992; 27: 716-22.
5. Storm H. Age-specific and standardized incidence rates. Europe, Denmark. In: Cancer Incidence in Five Continents (Parkin DM, Muir CS, Whelan SL et al. eds), Vol. VI, IARC Scientific Publications no. 120. Lyon: IARC, 1992; 563-4.
6. Brandrup F. Aetiological studies on psoriasis [thesis]. Odense: Odense University Press, 1985.
7. Pihl J, Brandt B. Cancer incidence in Denmark 1994. Danish National Board of Health. Copenhagen: Sundhedsstatistikken 1997; 7.
8. Percy C, van Holten V, Muir C. International Classification of Diseases for Oncology, 2nd edn. Geneva: World Health Organisation, 1990.
9. Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator. DHHS Publication no. NIH 79-1649. Washington, DC. US Government Printing Office, 1979.
10. Lindelöf B, Sigurgeirsson B, Tegner E et al. PUVA and cancer: a large scale epidemiological study. Lancet 1991; 338: 91-9.
11. Robinson LL. Second primary cancers after childhood cancer. Editorial. Br Med J 1996; 312: 861-2.
12. Stern RS, Lange R. Members of the Photochemotherapy Follow-up Study. Non melanoma skin cancer occuring in patients with PUVA five to ten years after first treatment. J Invest Dermatol 1998; 91: 120-4.
13. Stern RS, Laird N. For the Photochemotherapy Follow-up Study. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-64.
14. Stern RS. Metastatic squamous cell cancer after psoralen photochemotherapy. (Letter.) Lancet 1994; 344: 1644-5.
15. Østerlind A, Hjalgrim H, Kulinsky B, Frentz G. Skin cancer as a cause of death in Denmark. Br J Dermatol 1991; 125: 580-2.
16. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A-radiation (PUVA). N Engl J Med 1997; 336: 1041-5.